Articles tagged with Mitochondrial Diseases
Researchers at UCLA have identified a method to correct human mitochondrial mutations by targeting corrective RNAs, which could lead to treating a range of mitochondrial diseases. The study builds on previous work that uncovered a role for an essential protein in regulating RNA import into mitochondria.
A recent study by University of Colorado Boulder researchers has revealed a surprising connection between mitochondria and the endoplasmic reticulum, two critical cell organelles. Mitochondrial defects have been linked to various diseases, including diabetes, cardiovascular disease, and stroke.
The study found two DNA modifications in mitochondrial genomes that regulate gene expression, similar to those in nuclear genomes. This discovery implies a system of gene control in mitochondria, which may contribute to cancer and other age-related diseases.
A study published in EMBO Molecular Medicine suggests a novel therapy for mitochondrial diseases in children, using the oral drug probucol. The research reveals that probucol prevents and reverses kidney disease in mice with a genetic deficiency, raising levels of coenzyme Q10 and correcting signaling abnormalities.
Researchers at NIST have developed a technique to extract individual mitochondria from cells, enabling further study of genetic mutations behind neuromuscular disorders. This breakthrough could lead to a better understanding of mitochondrial-based diseases and potential treatments.
Researchers studied mitochondrial gene function in Caenorhabditis elegans to understand its impact on human diseases. They found that certain genes impair respiratory capacity and anesthesia response, providing clues for targeted therapies and potential treatments.
OHSU researchers develop gene therapy to prevent inherited diseases such as cancer, diabetes, and neurodegenerative diseases by transferring healthy mitochondria into eggs. The breakthrough could help break the chain of maternally-based diseases passed from generation to generation.
Scientists at Stanford University School of Medicine have devised a new biological marker to monitor mitochondrial disorders, which cause organ failure, seizures, and premature death. The discovery enables researchers to hunt for treatments and helps physicians check patients' status before health crises erupt.
A study published in the American Journal of Human Genetics reveals a significant presence of mitochondrial DNA mutations in the general population. Researchers found that at least 1 in 200 individuals harbor pathogenic mitochondrial DNA mutations, which may lead to diseases such as muscle weakness and diabetes.
Scientists have created a comprehensive 'parts list' to date for mitochondria, including nearly 1,100 proteins, with insights gained into the biological roles and evolutionary histories of key proteins. The researchers identified a mutation in a novel gene as the cause behind one devastating mitochondrial disease.
Researchers at UC Irvine found a single mitochondrial DNA mutation causes degenerative heart and muscle disease in mice, highlighting the importance of mitochondrial DNA in human health. The study's findings could lead to new treatments for age-related diseases affecting millions worldwide.
Researchers developed a computational model to study mitochondrial disease inheritance in mice, revealing how mtDNA is divided and separated during embryo formation. The model accounts for the 'mitochondrial genetic bottleneck' and could help predict a child's risk of developing maternally inherited mitochondrial diseases.
Researchers have identified a mitochondrial genetic bottleneck that affects the inheritance of mtDNA, leading to varying severity and location of disease. This breakthrough may enable predicting disease risk and severity in children, previously difficult to forecast.
A new study found trichloroethylene to be a risk factor for parkinsonism, a group of nervous disorders with symptoms similar to Parkinson's disease. The study showed that chronic exposure to TCE can lead to degenerative changes in the brain, including reduced mitochondrial function and dopamine neuron damage.
Researchers found a metabolic state that enables worms to slow their rate of aging despite cellular defects. The study's findings could contribute to the creation of gene therapies to reverse or lessen the effects of mitochondrial diseases.
Researchers at the University of Oregon have discovered zebrafish as an ideal model for studying COX deficiencies, which can lead to fatal metabolic disorders. The use of zebrafish allows scientists to visualize early stages of mitochondrial impairments and identify specific targets for potential drug therapies.
OHSU researchers found that beta amyloid can be found both inside and outside of brain cell mitochondria in Alzheimer's mice, suggesting a key role in the disease. Mitochondrial oxidative damage may contribute to the progression of Alzheimer's by producing hydrogen peroxide.
A multidisciplinary team at UCI will investigate the connection between genetic variations in mitochondria and metabolic syndrome symptoms. The research may lead to new diagnostic tools and treatments for conditions like diabetes and cardiovascular disease.
Defects in mitofusin 2, a critical mitochondrial fusion gene, underlie CMT type 2A. Gene therapy may alleviate symptoms by restoring lost gene function.
Researchers have successfully created a new kind of mouse by replacing its genetic material with that from another species, paving the way for studies on mitochondrial medicine. The goal is to improve treatment options for people with currently untreatable diseases, such as infertility, diabetes, and neurodegenerative disorders.
A damaged DNA synthesis enzyme has been shown to cause progressive muscle weakening in a rare eye condition. The researchers found that the faulty enzyme makes errors ten-fold more frequently than healthy individuals, leading to accumulation of mistakes and muscle degeneration.
Yale researchers have created a new method to record electrical activities within living cells, providing insights into degenerative neurological diseases like Parkinson's. The technique, which allows scientists to study inaccessible parts of cells, has already led to findings on how neurons learn and remember.
A $6.5-million study, the largest of its kind, aims to prevent deterioration in patients with Huntington's disease. The CARE-HD trial tests two treatments: experimental drug Remacemide and nutritional supplement CoQ10 to slow disease progression.
Researchers have developed a new method to examine mitochondria in the living brain using PET scanning, linking mitochondrial energy deficits to Parkinson's disease. They found that mild mitochondrial damage converts glutamate from a transmitter to a toxin, leading to nerve cell death.
Researchers identify a gene on chromosome 4 as a potential cause of Parkinson's disease, shedding light on the mysterious origins of this debilitating condition. The discovery may lead to genetic testing, early diagnosis, and treatment options for all forms of Parkinson's disease.